Table 3.
Echocardiographic data
| COVID‐19 (n = 13) | Controls (n = 21) | P‐value | |
|---|---|---|---|
| LVEDV, mL | 109 [95–119] | 101 [89–110] | 0.395 |
| LVEF, % | 67 [61–72] | 64 [60–65] | <0.001 |
| IVS thickness, mm | 12 [11–13] | 11 [10–12] | 0.024 |
| PW thickness, mm | 11 [10–11] | 10 [9–11] | 0.045 |
| LV mass, g/m2 | 88 [75–108] | 89 [80–102] | 0.915 |
| LV RWT, cm | 0.46 [0.43–0.54] | 0.40 [0.38–0.44] | 0.008 |
| LV geometry | <0.001 | ||
| Normal geometry | 0 (0) | 14 (66) | |
| Concentric remodelling | 10 (77) | 5 (24) | |
| Concentric hypertrophy | 1 (8) | 2 (10) | |
| Eccentric hypertrophy | 2 (15) | 0 (0) | |
| LAVI, mL/m2 | 24 [22–28] | 30 [27–46] | 0.007 |
| RV basal diameter, mm | 36 [32–38] | 40 [36–43] | 0.151 |
| RV/LV ratio | 0.8 [0.7–0.9] | 0.8 [0.7–1.0] | 0.567 |
| RVEDA, cm2 | 21 [19–23] | 18 [16–22] | 0.249 |
| RV FAC, % | 42 [40–56] | 47 [43–49] | 0.669 |
| TAPSE, mm | 22 [17–26] | 25 [21–27] | 0.463 |
| S′ RV wave, cm/s | 14 [13–16] | 15 [13–15] | 0.481 |
| RAVI, mL/m2 | 21 [15–29] | 32 [18–38] | 0.220 |
Values are given as n (%), or median [interquartile range].
FAC, fractional area change; IVS, interventricular septum; LAVI, left atrial volume index; LV, left ventricle; LVEDV, left ventricular end‐diastolic volume; LVEF, left ventricular ejection fraction; PW, posterior wall; RAVI, right atrial volume index; RV, right ventricle; RVEDA, right ventricular end‐diastolic area; RWT, relative wall thickness; TAPSE, tricuspid annular plane systolic excursion.